Urgent FDA Recall for Chocolate Male Enhancement Supplement Containing Hidden Prescription Drug
The Food and Drug Administration (FDA) has issued an urgent recall for a chocolate male enhancement supplement after laboratory analysis confirmed the presence of Tadalafil, a potent prescription medication used to treat erectile dysfunction. The product, marketed as Rhino Choco VIP 10X by Brooklyn-based company USALESS.COM, is being pulled from the market due to the undeclared pharmaceutical ingredient, which is not permitted in over-the-counter dietary supplements.
Product Details and Recall Scope
The recall specifically targets the 10-gram/12-piece chocolate bar supplement, which is packaged in a distinctive black cardboard box. Key identifying information includes the Universal Product Code (UPC) 724087947668 and an expiration date stamped on the back of October 2027. USALESS.COM has stated that it has immediately removed the product from its online store pending resolution of the contamination issue. No adverse health events have been reported in connection with this recall to date.
Serious Health Risks from Undeclared Tadalafil
Tadalafil, the active ingredient in the prescription drug Cialis, belongs to a class of medications known as phosphodiesterase type‑5 (PDE‑5) inhibitors. Its presence in an unregulated supplement poses significant dangers, particularly for individuals with certain medical conditions. The FDA recall notice highlights that Tadalafil can interact dangerously with nitrates, which are commonly prescribed for chest pain (angina) in patients with diabetes, high blood pressure, high cholesterol, or heart disease.
This interaction can cause a critical drop in blood pressure, leading to symptoms such as:
- Severe dizziness or fainting
- Increased risk of falls and injuries
- Heart attack or stroke due to reduced blood flow to vital organs
Even when used as prescribed under medical supervision, Tadalafil carries known side effects including headaches, indigestion, back pain, muscle aches, and dizziness. The risks are magnified when the drug is consumed unknowingly in a supplement, without proper dosage controls or medical oversight.
Regulatory Gaps in Supplement Oversight
This incident underscores a significant regulatory challenge: dietary supplements are not subject to the same rigorous pre-market approval process as prescription drugs in the United States. The FDA typically intervenes only after problems are reported, issuing warnings and recalls rather than proactively testing products before they reach consumers. This reactive approach has allowed contaminated supplements to enter the market, putting public health at risk.
Pattern of Similar Contamination Incidents
The Rhino Choco VIP 10X recall follows a similar pattern of contamination in the male enhancement supplement market. In December, StuffbyNainax LLC voluntarily recalled all lots of its MR.7 SUPER 700000 capsules after testing revealed the presence of both Tadalafil and Sildenafil (the active ingredient in Viagra). That product had been distributed nationwide to online customers between August and November 2025, though the specific trigger for that recall was not disclosed by the FDA.
These recurring incidents highlight an ongoing problem with adulterated supplements masquerading as natural products. Consumers are urged to exercise extreme caution when purchasing enhancement supplements, particularly those marketed online with aggressive claims. The FDA recommends consulting healthcare providers before using any supplement, especially for individuals with pre-existing medical conditions or those taking prescription medications.
